Stock 2105 LAEKNA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Laekna, Inc.

Equities

2105

KYG5340S1093

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:42 2024-06-28 EDT 		5-day change 1st Jan Change
5.21 HKD +1.76% Intraday chart for Laekna, Inc. -8.11% -73.82%
06-26 Laekna Administers First Dose of Weight Loss Drug in China During Phase I Clinical Trials; Shares Gain 6% MT
06-26 Laekna, Inc Doses Subject in Phase I Clinical Trial of LAE102 for the Treatment of Obesity CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LAEKNA, INC. Stock Laekna, Inc.
 260M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 121B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 113B
ARGENX SE Stock argenx SE
 26.02B -
BIONTECH SE Stock BioNTech SE
 19.39B -
GENMAB A/S Stock Genmab A/S
 15.91B
  1. Stock Market
  2. Equities
  3. 2105 Stock
  4. Charts Laekna, Inc.
  5. Sector Chart